CardioTech's hydrogel wound dressing gains FDA OK:
This article was originally published in Clinica
Executive Summary
CardioTech International has gained US FDA 510(k) clearance for its absorbent hydrogel wound and burn dressing, which it claims has a reduced tendency to adhere to skin lesions. The dressing, which does not need to be removed from the wound for inspection, is indicated for treating skin ulcers, pressure sores, abrasions, lacerations, incisions and burns, including those associated with resurfacing procedures, such as dermabrasion, chemical and laser resurfacing. The product is aimed at a potential $300m market, says the Woburn, Massachusetts firm.